Rare genetic deafness: genes and variants
Explore variant evidence for Rare genetic deafness across 14 analyzed proteins (GJB2, MYO7A, SLC26A4, MYO15A, TECTA and 9 more). Linked ClinVar records include 84 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 13 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Rare genetic deafness
GJB2: Gap junction beta-2 protein
Its connexin 26 channels support potassium and metabolite recycling within the cochlea and communication across epithelial gap junctions. Biallelic pathogenic variants are among the most common causes of congenital nonsyndromic hearing loss, while dominant variants can cause syndromic deafness with skin disease.
25 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in GJB2 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
MYO7A: Unconventional myosin-VIIa
Its actin-based motor supports stereocilia organization in inner-ear hair cells and transport processes in retinal cells. Biallelic pathogenic variants cause Usher syndrome type 1B, while other alleles can cause nonsyndromic hearing loss.
23 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in MYO7A have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
SLC26A4: Pendrin
SLC26A4, known as pendrin, is an anion exchanger that transports chloride, iodide, and bicarbonate without directly using sodium. It supports ion balance in the inner ear and thyroid, and SLC26A4 variants cause Pendred syndrome and inherited deafness.
14 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SLC26A4 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
MYO15A: Unconventional myosin-XV
An actin-based motor protein needed to build and maintain the stereocilia of inner-ear hair cells. Variants can cause severe nonsyndromic hearing loss.
5 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in MYO15A have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
TECTA: Alpha-tectorin
Its extracellular matrix organizes the tectorial membrane that mechanically couples sound-induced motion to cochlear hair cells. Dominant or recessive pathogenic variants cause nonsyndromic hearing loss, with characteristic frequency patterns depending on the affected region.
3 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in TECTA have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
EYA1: Protein phosphatase EYA1
It functions as a transcriptional coactivator and phosphatase in developmental programs that form the ear, kidney, and craniofacial structures. Haploinsufficiency causes branchio-oto-renal spectrum disorders with hearing loss, branchial anomalies, and variable renal malformations.
3 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in EYA1 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
OTOF: Otoferlin
It couples calcium entry to synaptic-vesicle fusion at inner hair-cell ribbon synapses, enabling rapid transmission of acoustic signals to the auditory nerve. Biallelic loss-of-function variants cause DFNB9 auditory neuropathy or nonsyndromic sensorineural hearing loss.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in OTOF have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
TMC1: Transmembrane channel-like protein 1
A pore-forming component of the mechanotransduction channel at the tips of cochlear hair-cell stereocilia. Variants can cause inherited hearing loss.
2 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in TMC1 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
KCNQ4: Potassium voltage-gated channel subfamily KQT member 4
Its potassium conductance is crucial for electrical homeostasis in cochlear outer hair cells and auditory pathways. Dominant pathogenic variants are a well-established cause of progressive nonsyndromic sensorineural hearing loss, classically DFNA2.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KCNQ4 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
SOX10: Transcription factor SOX-10
A transcription factor that guides development of neural-crest lineages, including melanocytes, Schwann cells, and enteric neurons. Variants can cause Waardenburg syndrome, sometimes with Hirschsprung disease.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SOX10 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
PCDH15: Protocadherin-15
It forms part of the tip-link complex that converts mechanical deflection of inner-ear hair bundles into electrical signals and also supports photoreceptor structure. Biallelic pathogenic variants cause Usher syndrome type 1F or nonsyndromic hearing loss.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PCDH15 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
COL4A5: Collagen alpha-5(IV) chain
It is essential for the alpha3-alpha4-alpha5 type IV collagen network that gives glomerular and cochlear basement membranes their mature mechanical properties. Pathogenic variants cause X-linked Alport syndrome, with progressive kidney disease, hearing loss, and characteristic ocular findings.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in COL4A5 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
MYO6: Unconventional myosin-VI
A reverse-direction actin motor involved in intracellular transport and organization of hair-cell stereocilia. Variants can cause inherited hearing loss.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MYO6 have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
USH2A: Usherin
It helps organize extracellular and membrane structures required for cochlear hair-cell and photoreceptor function. Biallelic pathogenic variants cause Usher syndrome type 2A or nonsyndromic retinitis pigmentosa and can also produce isolated hearing loss.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in USH2A have source records linked to Rare genetic deafness. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): MITF, EDNRB, HSD17B4 and KCNE1.
ClinVar pathogenic and likely pathogenic variants linked to Rare genetic deafness
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GJB2 R32H | 32 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| GJB2 R32C | 32 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| MYO6 H246R | 246 | Myosin motor | Pathogenic / likely pathogenic (★★★★) |
| GJB2 A40E | 40 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 R184Q | 184 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB2 A40G | 40 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 V84L | 84 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 M93I | 93 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 C169Y | 169 | Extracellular | Pathogenic / likely pathogenic (★★) |
| MYO7A S1471P | 1471 | FERM 1 | Pathogenic / likely pathogenic (★★) |
| SOX10 W142R | 142 | HMG box | Pathogenic / likely pathogenic (★★) |
| GJB2 G12V | 12 | Intramembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 W77R | 77 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 Q80P | 80 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 L90P | 90 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 V95M | 95 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB2 H100Y | 100 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB2 S199F | 199 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MYO15A G1418R | 1418 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A H133Y | 133 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A T165M | 165 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A G214R | 214 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R1873W | 1873 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A P1887L | 1887 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| SLC26A4 G209V | 209 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC26A4 L236P | 236 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC26A4 V239D | 239 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC26A4 E384G | 384 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC26A4 T416P | 416 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC26A4 G497S | 497 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 V37F | 37 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 R127C | 127 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| MYO15A R2204C | 2204 | MyTH4 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A A26E | 26 | Pathogenic / likely pathogenic (★★) | |
| MYO7A L366P | 366 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A G1298R | 1298 | FERM 1 | Pathogenic / likely pathogenic (★★) |
| EYA1 R440Q | 440 | Pathogenic / likely pathogenic (★★) | |
| GJB2 K122I | 122 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB2 N206S | 206 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MYO15A V2697A | 2697 | Tail | Pathogenic / likely pathogenic (★★) |
| MYO15A R2728H | 2728 | Tail | Pathogenic / likely pathogenic (★★) |
| MYO7A R83S | 83 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A R212H | 212 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A G519D | 519 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| MYO7A E1327K | 1327 | FERM 1 | Pathogenic / likely pathogenic (★★) |
| MYO7A L1858P | 1858 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| MYO7A R1883Q | 1883 | MyTH4 2 | Pathogenic / likely pathogenic (★★) |
| OTOF I515T | 515 | C2 3 | Pathogenic / likely pathogenic (★★) |
| OTOF R1792H | 1792 | C2 7 | Pathogenic / likely pathogenic (★★) |
| SLC26A4 A411P | 411 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC26A4 G672E | 672 | STAS | Pathogenic / likely pathogenic (★★) |
| SLC26A4 T721M | 721 | STAS | Pathogenic / likely pathogenic (★★) |
| SLC26A4 D724G | 724 | STAS | Pathogenic / likely pathogenic (★★) |
| TECTA T1866M | 1866 | ZP | Pathogenic / likely pathogenic (★★) |
| EYA1 L583P | 583 | Pathogenic / likely pathogenic (★★) | |
| GJB2 K15T | 15 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| MYO7A D218N | 218 | Myosin motor | Pathogenic / likely pathogenic (★★) |
| PCDH15 R134G | 134 | Cadherin 1 | Pathogenic / likely pathogenic (★★) |
| TMC1 D572N | 572 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| MYO7A M1V | 1 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 84.
Which prediction tools work for Rare genetic deafness
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaGenome (regulatory): 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 93 out of 100
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 91 out of 100
- EVE: 90 out of 100
- SIFT: 88 out of 100
- phyloP: 84 out of 100
- AlphaGenome (splicing): 73 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Rare genetic deafness variants (38 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Rare genetic deafness variants (28 pathogenic / likely pathogenic).
- Mutilating keratoderma also has ClinVar records linked to GJB2 variants; they fall in the same places as the Rare genetic deafness variants (15 pathogenic / likely pathogenic).
- Ichthyosis, hystrix-like, with hearing loss also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Rare genetic deafness variants (13 pathogenic / likely pathogenic).
- Autosomal dominant keratitis-ichthyosis-hearing loss syndrome also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Rare genetic deafness variants (13 pathogenic / likely pathogenic).
- Usher syndrome also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Rare genetic deafness variants (80 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Rare genetic deafness variants (26 pathogenic / likely pathogenic).
- Autosomal dominant nonsyndromic hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Rare genetic deafness variants (13 pathogenic / likely pathogenic).
- Hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Rare genetic deafness variants (4 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Rare genetic deafness variants (4 pathogenic / likely pathogenic).
- Pendred syndrome also has ClinVar records linked to SLC26A4 variants; they fall mostly in different places as the Rare genetic deafness variants (106 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to SLC26A4 variants; they fall mostly in different places as the Rare genetic deafness variants (106 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to MYO15A variants; they fall mostly in different places as the Rare genetic deafness variants (57 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to MYO15A variants; they fall mostly in different places as the Rare genetic deafness variants (3 pathogenic / likely pathogenic).
- Autosomal dominant nonsyndromic hearing loss also has ClinVar records linked to TECTA variants; they fall mostly in different places as the Rare genetic deafness variants (15 pathogenic / likely pathogenic).
- Branchiootorenal syndrome also has ClinVar records linked to EYA1 variants; they fall mostly in different places as the Rare genetic deafness variants (5 pathogenic / likely pathogenic).
- BOR syndrome also has ClinVar records linked to EYA1 variants; they fall mostly in different places as the Rare genetic deafness variants (4 pathogenic / likely pathogenic).
- Anterior segment anomalies and cataract also has ClinVar records linked to EYA1 variants; they fall mostly in different places as the Rare genetic deafness variants (3 pathogenic / likely pathogenic).
Diseases related to Rare genetic deafness
- Hearing loss, also linked to GJB2, MYO15A, MYO6, MYO7A and 5 more
- Monogenic hearing loss, also linked to COL4A5, GJB2, KCNQ4, MYO15A and 5 more
- Autosomal recessive nonsyndromic hearing loss, also linked to GJB2, MYO15A, MYO7A, OTOF and 4 more
- Nonsyndromic genetic hearing loss, also linked to GJB2, KCNQ4, MYO15A, MYO6 and 4 more
- Deafness, also linked to GJB2, MYO15A, MYO7A, OTOF and 4 more
- Autosomal dominant nonsyndromic hearing loss, also linked to GJB2, KCNQ4, MYO6, MYO7A and 2 more
- Ear malformation, also linked to MYO15A, MYO7A, TECTA and USH2A
- Usher syndrome, also linked to MYO7A, PCDH15 and USH2A
- Bilateral sensorineural hearing impairment, also linked to KCNQ4, OTOF and TMC1
- Retinitis pigmentosa, also linked to MYO7A and USH2A
- Auditory neuropathy, also linked to MYO7A and OTOF
- Sensorineural hearing loss, also linked to SLC26A4 and USH2A
Frequently asked questions
Which genes have records linked to Rare genetic deafness?
This view contains 14 analyzed proteins: GJB2, MYO7A, SLC26A4, MYO15A, TECTA and 9 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 84 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 13 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 155 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center